614
Participants
Start Date
October 31, 2016
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2029
Intermittent PD-1 inhibitor therapy
Continuous PD-1 inhibitor therapy
RECRUITING
Westmead Hospital, Westmead
RECRUITING
Calvary Mater Newcastle Hospital, Waratah
RECRUITING
Coffs Habour Health Campus - NCCI, Coffs Harbour
NOT_YET_RECRUITING
Riverina Cancer Care Centre Wagga Wagga, Wagga Wagga
RECRUITING
Alfred Hospital, Melbourne
RECRUITING
Monash Medical Centre, Clayton
RECRUITING
Mildura Base Public Hospital, Victoria
RECRUITING
Royal Brisbane and Womens Hospital, Herston
RECRUITING
Gold Coast University Hospital, Southport
RECRUITING
Sunshine Coast University Hospital, Birtinya
RECRUITING
Cairns Hospital, Cairns
RECRUITING
The Queen Elizabeth Hospital, Woodville
RECRUITING
Cross Cancer Institute, Edmonton
RECRUITING
BCCA - Surrey, Surrey
RECRUITING
BCCA - Vancouver, Vancouver
RECRUITING
BCCA - Victoria, Victoria
RECRUITING
Horizon Health Network, Fredericton
RECRUITING
Royal Victoria Regional Health Centre, Barrie
RECRUITING
Health Sciences North, Greater Sudbury
RECRUITING
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
RECRUITING
Kingston Health Sciences Centre, Kingston
RECRUITING
Waterloo Regional Health Network (WRHN), Kitchener
RECRUITING
London Health Sciences Centre Research Inc., London
RECRUITING
Trillium Health Partners - Credit Valley Hospital, Mississauga
RECRUITING
Lakeridge Health Oshawa, Oshawa
RECRUITING
Ottawa Hospital Research Institute, Ottawa
RECRUITING
Odette Cancer Centre, Toronto
RECRUITING
University Health Network, Toronto
RECRUITING
The Research Institute of the McGill University, Montreal
RECRUITING
Allan Blair Cancer Centre, Regina
RECRUITING
Saskatoon Cancer Centre, Saskatoon
Melanoma and Skin Cancer Trials Limited
OTHER
Canadian Cancer Trials Group
NETWORK